help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lambert-Messerlian, G. M.
Right arrow Articles by Schneyer, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lambert-Messerlian, G. M.
Right arrow Articles by Schneyer, A. L.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 45-50, Copyright © 1994 by Endocrine Society


ARTICLES

Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme- linked immunosorbent assay

GM Lambert-Messerlian, JE Hall, PM Sluss, AE Taylor, KA Martin, NP Groome, WF Crowley Jr and AL Schneyer
Reproductive Endocrine Unit, Massachusetts General Hospital, Boston 02114.

The endocrine feedback role of dimeric inhibin on FSH secretion from the pituitary has been well established in many species; however, evidence that inhibin is an important endocrine regulator of FSH in the human is more tenuous. One potential explanation for the equivocal data may be that the inhibin immunoassay used most widely in the human is a heterologous assay with an antiserum that exclusively recognizes the inhibin alpha-subunit in both its monomeric form and in inhibin dimers. The aim of the present study was to quantify serum inhibin levels in a variety of fertile and infertile men and women using a new ultrasensitive enzyme-linked immunosorbent assay that is specific for the dimeric form (alpha/beta) only. The specificity of the present assay was demonstrated by the absence of significant cross-reactivity with Mullerian inhibiting substance, transforming growth factor-beta, activin, FSH, LH, hCG, TSH, and hCG alpha and with the alpha-subunit of inhibin. The assay was sensitive to 1 pg/mL, and serial dilutions of human male and female serum samples paralleled the recombinant 32- kilodalton (kDa) dimeric inhibin standard curve. Complete recovery of exogenous recombinant 32-kDa inhibin added to serum was obtained. Mean serum inhibin levels ranged from a low of 5.7 +/- 0.6 pg/mL in the early follicular phase to 49.0 +/- 11.2 pg/mL in the midluteal phase of the normal menstral cycle and were elevated during ovulation induction (1250 pg/mL) and pregnancy (500 pg/mL). Interestingly, mean levels of dimeric inhibin in women with polycystic ovarian syndrome (PCOS) were indistinguishable from normal follicular phase. The most striking observation was the extremely low mean inhibin levels (< 2 pg/mL) found in normal men, GnRH-deficient men before any pulsatile GnRH treatment, and men with Klinefelter's syndrome, all of which were indistinguishable from levels observed in postmenopausal women. These observations in the male raise the possibly that 1) some forms of circulating and bioactive inhibin in the human are not detected by this assay due to either their conformation or the presence of a unique binding protein for endogenous inhibin that does not bind to recombinant 32-kDa inhibin; or 2) dimeric inhibin is not a major endocrine regulator of FSH in the human male. In addition, the relatively high dimeric inhibin levels at midcycle and in the luteal phase of the normal menstrual cycle, after gonadotropin stimulation, and during pregnancy suggest that dimeric inhibin is predominantly produced by dominant follicles, corpora lutea, and placental tissues.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. Wachs, M. S. Coffler, P. J. Malcom, and R. J. Chang
Comparison of Follicle-Stimulating-Hormone-Stimulated Dimeric Inhibin and Estradiol Responses as Indicators of Granulosa Cell Function in Polycystic Ovary Syndrome and Normal Women
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2920 - 2925.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, A. E. Taylor, J. Fox, G. M. Messerlian, J. M. Adams, and A. L. Schneyer
Follicular Arrest in Polycystic Ovary Syndrome Is Associated with Deficient Inhibin A and B Biosynthesis
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5582 - 5587.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, J. E. Hall, J. M. Adams, and A. E. Taylor
Relationship of Estradiol and Inhibin to the Follicle-Stimulating Hormone Variability in Hypergonadotropic Hypogonadism or Premature Ovarian Failure
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 826 - 830.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, P. C. Smith, and A. E. Taylor
Evidence of Early Ovarian Aging in Fragile X Premutation Carriers
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4569 - 4574.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. S. Dighe, F. J. Hayes, J. Khosravi, U. Bodani, and P. M. Sluss
Comparison of Inhibin A Immunoassays: Recommendation for Adoption of Standardized Reporting
Clin. Chem., April 1, 2004; 50(4): 767 - 769.
[Full Text] [PDF]


Home page
Reproductive SciencesHome page
M. P. Plevyak, G. M. Lambert-Messerlian, A. Farina, N. P. Groome, J. A. Canick, and H. M. Silver
Concentrations of Serum Total Activin A and Inhibin A in Preterm and Term Labor Patients: A Cross-Sectional Study
Reproductive Sciences, May 1, 2003; 10(4): 231 - 236.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, Y. L. Pagan, P. C. Smith, K. B. Rado, and J. E. Hall
Control of Follicle-Stimulating Hormone by Estradiol and the Inhibins: Critical Role of Estradiol at the Hypothalamus during the Luteal-Follicular Transition
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1766 - 1771.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. X. Liao, R. K. Moore, F. Otsuka, and S. Shimasaki
Effect of Intracellular Interactions on the Processing and Secretion of Bone Morphogenetic Protein-15 (BMP-15) and Growth and Differentiation Factor-9. IMPLICATION OF THE ABERRANT OVARIAN PHENOTYPE OF BMP-15 MUTANT SHEEP
J. Biol. Chem., January 31, 2003; 278(6): 3713 - 3719.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Y.K. Yong, D. T. Baird, K.J. Thong, A. S. McNeilly, and R. A. Anderson
Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation
Hum. Reprod., January 1, 2003; 18(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, A. E. Taylor, K. A. Martin, and J. E. Hall
Serum Inhibin B in Polycystic Ovary Syndrome: Regulation by Insulin and Luteinizing Hormone
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5559 - 5565.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer
Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium
Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. M. Plant and G. R. Marshall
The Functional Significance of FSH in Spermatogenesis and the Control of Its Secretion in Male Primates
Endocr. Rev., December 1, 2001; 22(6): 764 - 786.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. J. Hayes, N. Pitteloud, S. DeCruz, W. F. Crowley Jr., and P. A. Boepple
Importance of Inhibin B in the Regulation of FSH Secretion in the Human Male
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5541 - 5546.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. S.E. Laven, B. Imani, M. J.C. Eijkemans, F. H. de Jong, and B. C.J.M. Fauser
Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility
Hum. Reprod., July 1, 2001; 16(7): 1359 - 1364.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, Z. A. Smith, D. K. Pauler, and J. E. Hall
Differential Regulation of Inhibin A and Inhibin B by Luteinizing Hormone, Follicle-Stimulating Hormone, and Stage of Follicle Development
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2531 - 2537.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt and A. L. Schneyer
Differential Regulation of Inhibin B and Inhibin A by Follicle-Stimulating Hormone and Local Growth Factors in Human Granulosa Cells from Small Antral Follicles
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 330 - 336.
[Abstract] [Full Text]


Home page
Reproductive SciencesHome page
G. M. Lambert-Messerlian, H. M. Silver, F. Petraglia, S. Luisi, I. Pezzani, W. M. Maybruck, W. A. Hogge, K. Hanley-Yanez, J. M. Roberts, L. M. Neveux, et al.
Second-Trimester Levels of Maternal Serum Human Chorionic Gonadotropin and Inhibin A as Predictors of Preeclampsia in the Third Trimester of Pregnancy
Reproductive Sciences, May 1, 2000; 7(3): 170 - 174.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
Z. Blumenfeld, I. Avivi, M. Ritter, and J. M. Rowe
Preservation of Fertility and Ovarian Function and Minimizing Chemotherapy-Induced Gonadotoxicity in Young Women
Reproductive Sciences, September 1, 1999; 6(5): 229 - 239.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, J. M. Adams, P. M. Sluss, and J. E. Hall
Inhibin A and Inhibin B Responses to Gonadotropin Withdrawal Depends on Stage of Follicle Development
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2163 - 2169.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
N. H. I. Hjollund, T. K. Jensen, J. P. E. Bonde, T. B. Henriksen, A.-M. Andersson, and N. E. Skakkebęk
Is glycosylated haemoglobin a marker of fertility? A follow-up study of first-pregnancy planners
Hum. Reprod., June 1, 1999; 14(6): 1478 - 1482.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. E. Hall, C. K. Weltand, and D. W. Cramer
Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome
Hum. Reprod., February 1, 1999; 14(2): 409 - 415.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, D. J. McNicholl, A. E. Taylor, and J. E. Hall
Female Reproductive Aging Is Marked by Decreased Secretion of Dimeric Inhibin
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 105 - 111.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. J. Hayes, J. E. Hall, P. A. Boepple, and W. F. Crowley Jr.
Differential Control of Gonadotropin Secretion in the Human: Endocrine Role of Inhibin
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1835 - 1841.
[Full Text]


Home page
EndocrinologyHome page
N. Di Simone, H. A. Hall, C. Welt, and A. L. Schneyer
Activin Regulates {beta}A-Subunit and Activin Receptor Messenger Ribonucleic Acid and Cellular Proliferation in Activin-Responsive Testicular Tumor Cells
Endocrinology, March 1, 1998; 139(3): 1147 - 1155.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, G. Lambert-Messerlian, W. Zheng, W. F. Crowley Jr., and A. L. Schneyer
Presence of Activin, Inhibin, and Follistatin in Epithelial Ovarian Carcinoma
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3720 - 3727.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. K. Welt, K. A. Martin, A. E. Taylor, G. M. Lambert-Messerlian, W. F. Crowley Jr., J. A. Smith, D. A. Schoenfeld, and J. E. Hall
Frequency Modulation of Follicle-Stimulating Hormone (FSH) during the Luteal-Follicular Transition: Evidence for FSH Control of Inhibin B in Normal Women
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2645 - 2652.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Pigny, R. Desailloud, C. Cortet-Rudelli, A. Duhamel, D. Deroubaix-Allard, A. Racadot, and D. Dewailly
Serum {alpha}-Inhibin Levels in Polycystic Ovary Syndrome: Relationship to the Serum Androstenedione Level
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1939 - 1943.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society